BB&T Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.23M Buy
30,183
+8,508
+39% +$360K 0.01% 719
2019
Q2
$931K Sell
21,675
-4,200
-16% -$162K 0.01% 840
2019
Q1
$993K Buy
25,875
+972
+4% +$37.1K 0.01% 800
2018
Q4
$879K Sell
24,903
-4,258
-15% -$154K 0.01% 783
2018
Q3
$1.12M Buy
29,161
+5,813
+25% +$203K 0.01% 783
2018
Q2
$763K Buy
23,348
+7,963
+52% +$240K 0.01% 902
2018
Q1
$420K Buy
15,385
+807
+6% +$21.9K ﹤0.01% 1097
2017
Q4
$361K Buy
14,578
+454
+3% +$12.5K ﹤0.01% 1116
2017
Q3
$411K Buy
14,124
+282
+2% +$7.79K 0.01% 1039
2017
Q2
$383K Buy
+13,842
New +$367K 0.01% 1058
2016
Q1
Sell
-84,393
Closed -$1.56M 1164
2015
Q4
$1.56M Sell
84,393
-415
-0.5% -$7.44K 0.03% 406
2015
Q3
$1.39M Buy
84,808
+1,910
+2% +$32.6K 0.03% 424
2015
Q2
$1.47M Buy
82,898
+5,609
+7% +$100K 0.03% 422
2015
Q1
$1.37M Buy
+77,289
New +$1.22M 0.03% 434

Other funds holding BSX

BB&T Securities's BSX Position: Q3 2019 in Review

BB&T Securities increased its Boston Scientific (BSX) stake by 39% in Q3 2019, buying an estimated $360K and bringing the position to 30,183 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #719.

BB&T Securities first reported a position in BSX in Q1 2015 and has held it in 14 quarters since. The position peaked at $1.56M in Q4 2015. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • BB&T Securities held 30,183 shares of Boston Scientific worth $1.23M as of Q3 2019.
  • BB&T Securities bought 8,508 Boston Scientific shares in Q3 2019, an estimated $360K.
  • Boston Scientific made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #719 holding.
  • BB&T Securities first reported a position in Boston Scientific in Q1 2015 and has held it in 14 quarters since.
  • BB&T Securities's Boston Scientific position peaked at $1.56M in Q4 2015.
  • 771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.